Publication

Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH

BMC Gastroenterology 19(1):228, 2019

Kristiansen MB, Veidal SS, Christoffersen C, Feigh M, Hansen HH, Vrang N, Roth JD, Erickson M, Young M, Adorini L, Jelsing J

Share this page

Resource Library

Related resources

Metabolic, biochemical, histopathological, and transcriptomic effects of Seladelpar in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH

Animal models of type 2 diabetes, obesity and nonalcoholic steatohepatitis – clinical translatability and applicability in preclinical drug development

Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source

Metabolic, biochemical, histological, and transcriptomic effects of Firsocostat in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH 

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 2650